Radiotherapy for gynecologic cancer.
The past year has not seen any breakthroughs in radiation treatment of gynecologic cancer. In reference to cervix cancer, important contributions concerning side effects and the role of radiosensitizers were published. The lack of randomized trials dealing with adjuvant radiotherapy is obvious. Improvement based on technical progress can be expected. For ovarian cancer, an important review about whole abdominal irradiation as adjuvant therapy was published. The long-term complication rate of whole abdominal irradiation is acceptable, but whether adjuvant whole abdominal irradiation has an effect upon survival superior to that of chemotherapy is still discussed. Combined treatment with chemotherapy and radiation therapy for advanced ovarian cancer is feasible, but there is no proof that the addition of radiotherapy improves survival. Literature about endometrial cancer was scarce in 1992 and did not contribute to the major question: Does adjuvant radiotherapy have any effect in endometrial cancer?
Bertelsen
K
K
Department of Oncology, Odense University Hospital, Denmark.
Jakobsen
A
A
D016889:Endometrial Neoplasms / Q000532:radiotherapy; D005260:Female; D005833:Genital Neoplasms, Female / Q000532:radiotherapy*; D006801:Humans; D010051:Ovarian Neoplasms / Q000532:radiotherapy; D011878:Radiotherapy / Q000009:adverse effects; D002583:Uterine Cervical Neoplasms / Q000532:radiotherapy